U.S. Hotel and Resort REITs Stock News

Thinking about what to do with DoorDash stock right now? You are definitely not alone. Whether you have been riding the wave for the past year or are just peeking at the ticker for the first time, there is no denying that DoorDash has been on the move. In the past year, the stock has nearly doubled, delivering a massive 88% total return. The past three months alone have seen a 21% jump, which is remarkable momentum for a company that is already a household name in food delivery. The energy...

Earlier this month, Establishment Labs Holdings raised its 2025 revenue guidance to a range of US$208 million to US$212 million and reported second-quarter sales of US$51.3 million, up from US$44.12 million a year prior. An interesting aspect is the company's forecast of at least US$40 million in US Motiva revenue for the year, marking the growing importance of its US operations in total sales. We'll explore how the stronger full-year revenue outlook and US Motiva momentum could influence...

If you’ve been tracking Brookfield Business (NYSE:BBUC), the recent renewal of its normal course issuer bids for both limited partnership units and class A exchangeable subordinate voting shares probably caught your eye. Management is sending a clear message about their confidence in the firm’s intrinsic value, especially with buyback programs often interpreted as a commitment to shareholder returns. The regulatory filings released alongside this move suggest Brookfield is focused on capital...

ServiceNow (NYSE:NOW) recently caught investor attention after shares bounced nearly 4% in the past week, shrugging off some month-long pressure that saw the stock dip about 7%. There has been no single headline catalyst driving this latest move. With ServiceNow’s valuation already a subject of debate, even modest volatility prompts a closer look. When a tech leader like this changes direction, it naturally raises questions about what could be next for the price and whether this is a good...

EOG Resources reported its second-quarter earnings, showing year-over-year declines in both revenue and net income, and also released updated production guidance for the upcoming quarter and full year. Despite lower financial results, the company completed a US$600 million share buyback this quarter, bringing total repurchases to over US$5.57 billion under its current program. We'll examine how EOG Resources' updated production outlook informs the company's investment narrative and...

Premialab recently announced a partnership with Nasdaq eVestment™, integrating their data analytics platforms to provide institutional investors with enhanced tools for strategy analysis, portfolio construction, and risk monitoring. This collaboration gives users seamless access to expansive datasets and proprietary quantitative indices, streamlining research workflows and supporting comprehensive investment insights within a unified environment. We'll explore how the expanded analytical...

NasdaqCM:UBXG 1 Year Share Price vs Fair Value Explore U-BX Technology's Fair Values from the Community and select...

NasdaqCM:LFVN 1 Year Share Price vs Fair Value Explore LifeVantage's Fair Values from the Community and select yours...

If you own a piece of Royal Caribbean Cruises (RCL) or have been eyeing its stock, the recent moves might have left you wondering what’s next. While there hasn’t been a specific headline moving the stock this week, the shares have drifted a bit, catching the attention of investors focused on valuation and future growth. Sometimes, a quiet period can reflect investor sentiment as much as major news, and with RCL now sitting at $329.12, it may be a good time to look beneath the...

Trying to figure out what to do with TKO Group Holdings stock right now? You are not alone. With some eye-catching moves in recent months, investors are wondering if the stock's rapid momentum really reflects deeper value or just market excitement. Over the past year, TKO has delivered an impressive 53% total return, with especially strong gains in the last 30 days (over 8%) and nearly 17% in the last quarter alone. After a brief dip this week, the stock is still comfortably above its...

Certainly! Here is the revised article text with em dashes replaced and formatting improved: If you have been watching Medtronic (MDT) lately, you might have noticed the stir from its latest boardroom shake-up. Just this week, Medtronic announced it is expanding its board and forming two new oversight committees, following productive engagement with activist investor Elliott Investment Management. These moves, which include adding leaders with fresh medical device expertise, are intended to...

BGC Group, Inc. recently announced a fixed-income exchange offer for its US$700 million 6.150% senior unsecured notes due 2030, allowing investors to exchange their existing bonds under new terms. This move reflects BGC Group’s efforts to actively manage its debt profile, signaling a focus on improving financial flexibility and extending debt maturities. We’ll explore how BGC’s exchange offer for its senior notes could impact the company’s investment outlook and future growth plans. Uncover...

CompoSecure announced its second quarter and six-month 2025 earnings, reporting a net loss of US$26.13 million for the quarter and US$4.63 million for the half-year, alongside a sharp drop in sales compared to the prior year. For both periods, the company moved from profitability to loss and experienced a significant decrease in basic and diluted earnings per share, marking a sharp year-over-year downturn in financial performance. Given these unexpected losses and reduced sales, we’ll assess...

Certainly! Here’s the revised article with em dashes removed and rephrased for clarity: So, you are thinking about what to do with MercadoLibre’s stock right now. Maybe you already own shares and are debating whether to hold or trim, or perhaps you are wondering if this is the right moment to jump in. Either way, MercadoLibre has likely caught your attention for good reason. Over the past year, the Latin American e-commerce leader has not only outperformed many of its peers but has also...

Trying to Decide What to Do With Thermo Fisher Scientific Stock? Let’s talk about where Thermo Fisher Scientific sits right now, especially if you’ve been weighing whether to buy, hold, or step back for a while. The stock price is fresh off some interesting moves. After dropping over 18% in the last year, TMO has posted a strong comeback in recent weeks, gaining nearly 24% over the past three months and 22% in the last 30 days. Even just in the last week, shares ticked up by over 2%. Clearly,...

Anyone keeping an eye on Cintas (CTAS) might be wondering what is behind its latest price shift. The stock has been treading water this week, moving just a hair higher, with no headline-making events pushing it either way. While there is not a flashy earnings surprise or big acquisition to dissect, sometimes the absence of drama is noteworthy on its own. For investors, a quiet price move like this can be a subtle nudge to pause and rethink whether the current valuation tells the whole...

Wondering What to Do With Pinterest Stock? Here's What You Need to Know If you have Pinterest stock on your watchlist or already in your portfolio, you are definitely not alone. Investors are watching closely as social media platforms compete for attention in a crowded online world, each striving to establish a unique niche. Pinterest has quietly but consistently rewarded its supporters, posting a 16% return year-to-date and over 68% in total returns over the last three years. However,...

If you are wrestling with what to do about Meta Platforms stock right now, you are definitely not alone. In an environment where tech giants seem to headline every market conversation, it is easy to wonder whether Meta's incredible journey has more room to run or if it's time for caution. Over just the last month, the stock has pushed nearly 5% higher, and if you zoom out to the last year, the gains swell to an impressive 40%. Even more staggering, anyone who held on for three years has now...

If you are considering what to do with Jabil stock, you are far from alone. The company has caught the attention of both growth seekers and value-oriented investors, thanks to its impressive performance and intriguing valuation story. Over the past year, Jabil’s stock price has skyrocketed by 88%, making it one of the standouts in its sector. Zoom out further, and the picture looks even better. The total return for shareholders over the last three and five years has been 231% and over 500%,...

Thinking about Dell Technologies stock? You are not alone. Whether you are deciding whether to add more to your position or just looking to understand why this company is such a hot topic, it is hard to ignore Dell’s recent momentum. Shares have bounced around a bit in the last month, dipping about 0.4%, but if you zoom out the picture gets a lot rosier. Over the past three months, Dell Technologies has surged nearly 15%, and over the last year, the stock is up roughly 17%. This does not even...

Belite Bio (NasdaqCM:BLTE) just delivered its second-quarter earnings, and while the company is still in the red, something has changed: the loss is shrinking. For the quarter ended June, the net loss came in at $9.49 million compared to $16.32 million a year ago, and losses per share followed suit. Investors have been watching closely for any sign the biotech’s cash burn is easing, and this result might attract some attention. It is not common to see such a significant improvement,...

Has Eli Lilly (LLY) just put itself back on your radar? The company’s share price has edged up slightly in recent sessions. A modest 0.3% one day pop sits alongside a 6.8% gain on the week. However, stepping back, it’s actually down nearly 7% this month, and more than 25% off highs from a year ago. For investors, those red numbers are hard to ignore, especially given Eli Lilly’s pivotal role in pharmaceuticals and its strong reputation for pipeline innovation. This movement comes against the...

NYSE:RSKD 1 Year Share Price vs Fair Value Explore Riskified's Fair Values from the Community and select yours...

Earlier this week, Edwards Lifesciences reported strong Q2 results, raised its 2025 guidance, and announced a US$500 million accelerated share repurchase agreement, building on over US$800 million in shares repurchased during 2025. Despite a legal setback affecting margins, the company sharpened its focus on heart valve therapies after divesting its critical care business, while highlighting robust financial health and ongoing innovation. With the company’s new share repurchase program...